Donor Egg

Screening of Egg Donors

Egg donors undergo a medical, genetic and psychological screening process to help both the clinic and the donor decide if donation is the right path for them.  Donors undergoing treatment at CARE all have an extended genetic screening evaluation (a blood test) to assess their risk for being a carrier of certain genetic diseases.  Testing includes cystic fibrosis, Fragile X, spinal muscular atrophy, alpha and beta thalassemia, sickle cell anemia, Tay Sachs DNA, Fanconi’s anemia group C, Gauchers Disease, Glycogen Storage Disease Type IA, Joubert’s Syndrome 2, Maple Syrup Disease Type 1A/1B, Mucolipidosis Type IV, Nemaline myopathy,  Bloom Syndrome, Canavan Disease, Dihydrolipoamide dehydrogenase deficiency, Familial Dysautonomia, Familial Hyperinsulinism,  Neiman-Pick Type A and B, Usher’s Syndrome Type If, Usher’s syndrome Type III, Walker-Warburg Syndrome.  Additionally a genetics counselor provides the intended parent with a concise report that reviews their pertinent positive family history as well as their blood results.  The ovarian reserve of the donor is assessed by an AMH (antimullerian hormone) level as well as an antral follicle count.  This information coupled with the donor’s body weight allows us to customize our stimulation protocol of the donor. 

CARE Fertility tries to provide as much information as possible to assist the intended parents in choosing the right donor for them!

Contact Us

For more information on Donor Egg, please contact CARE Fertility.